Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).
NCT07177612 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 20000
Last updated 2025-09-22
Summary
The goal of this observational study is to assess the if short educational videos about #LILAC-for-Lpa are feasible and accepted in improving the confidence, testing, and management on Lipoprotein(a).
Conditions
- Lipoprotein(a)
- Lipoprotein(a), Hyper-Lp(a)-Emia
Sponsors & Collaborators
-
Changi General Hospital
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-09
- Primary Completion
- 2028-08-31
- Completion
- 2028-12-31
Countries
- Australia
- Malaysia
- Singapore
Study Locations
More Related Trials
-
BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease
NCT05399745 ·Status: RECRUITING
-
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NCT04227678 ·Status: RECRUITING ·Phase: NA
-
The Natural History of Mucolipidosis Type IV
NCT01067742 ·Status: TERMINATED
-
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
NCT01427725 ·Status: COMPLETED
-
Kinetic Study of Lp(a) and PCSK9 in Humans
NCT04247048 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)
NCT00571272 ·Status: SUSPENDED
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
NCT03161106 ·Status: WITHDRAWN ·Phase: NA
-
Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
NCT01427712 ·Status: COMPLETED
-
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489 ·Status: RECRUITING
-
Minimization of IntraLipid Versus Omegaven
NCT01247012 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
NCT00004347 ·Status: UNKNOWN ·Phase: PHASE2
-
THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.
NCT02381769 ·Status: COMPLETED ·Phase: NA
-
Bileacid Malabsorption and GLP-1 Secretion
NCT03009916 ·Status: COMPLETED ·Phase: PHASE4
-
N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy
NCT03499249 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Undiagnosed Lysosomal Acid Lipase Deficiency
NCT01716728 ·Status: UNKNOWN ·Phase: NA
-
Fat Malabsorption in Chronic Pancreatitis
NCT02849704 ·Status: COMPLETED ·Phase: PHASE2
-
Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency
NCT01488097 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases
NCT04475276 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)
NCT04737720 ·Status: COMPLETED
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
NCT01528917 ·Status: COMPLETED
-
The Effects of Metreleptin in Congenital Leptin Deficiency
NCT04063488 ·Status: COMPLETED
-
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)
NCT04568434 ·Status: COMPLETED ·Phase: PHASE3